These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30747361)

  • 1. High BAFF expression associated with active disease in systemic lupus erythematosus and relationship with rs9514828C>T polymorphism in TNFSF13B gene.
    Marín-Rosales M; Cruz A; Salazar-Camarena DC; Santillán-López E; Espinoza-García N; Muñoz-Valle JF; Ramírez-Dueñas MG; Oregón-Romero E; Orozco-Barocio G; Palafox-Sánchez CA
    Clin Exp Med; 2019 May; 19(2):183-190. PubMed ID: 30747361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of TNFSF13B polymorphisms and BAFF expression in rheumatoid arthritis and primary Sjögren's syndrome patients.
    Santillán-López E; Muñoz-Valle JF; Oregon-Romero E; Espinoza-García N; Treviño-Talavera BA; Salazar-Camarena DC; Marín-Rosales M; Cruz A; Alvarez-Gómez JA; Sagrero-Fabela N; Cerpa-Cruz S; Palafox-Sánchez CA
    Mol Genet Genomic Med; 2022 Jun; 10(6):e1950. PubMed ID: 35411715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFSF13B rs9514828 gene polymorphism and soluble B cell activating factor levels: Association with apical periodontitis.
    Cruz A; Gascón LG; Palafox-Sánchez CA; Flores-García C; Espinoza-García N; Sagrero-Fabela N; Cintra LTA; Mejía-Flores R; Salazar-Camarena DC
    Int Endod J; 2023 Apr; 56(4):419-431. PubMed ID: 36508294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis.
    Friebus-Kardash J; Trendelenburg M; Eisenberger U; Ribi C; Chizzolini C; Huynh-Do U; Lang KS; Wilde B; Kribben A; Witzke O; Dolff S; Hardt C
    BMC Nephrol; 2019 Nov; 20(1):430. PubMed ID: 31752784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell activating factor and related genetic variants in lupus related atherosclerosis.
    Theodorou E; Nezos A; Antypa E; Ioakeimidis D; Koutsilieris M; Tektonidou M; Moutsopoulos HM; Mavragani CP
    J Autoimmun; 2018 Aug; 92():87-92. PubMed ID: 29859654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.
    Ortiz-Aljaro P; Montes-Cano MA; García-Lozano JR; Aquino V; Carmona R; Perez-Florido J; García-Hernández FJ; Dopazo J; González-Escribano MF
    Sci Rep; 2022 Jul; 12(1):11219. PubMed ID: 35780200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell activating factor promoter polymorphisms in egyptian patients with systemic lupus erythematosus.
    Zayed RA; Sheba HF; Abo Elazaem MA; Elsaadany ZA; Elmessery LO; Mahmoud JA; Abdel Rahman DR; Abdou FR
    Ann Clin Lab Sci; 2013; 43(3):289-94. PubMed ID: 23884224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    González-Serna D; Ortiz-Fernández L; Vargas S; García A; Raya E; Fernández-Gutierrez B; López-Longo FJ; Balsa A; González-Álvaro I; Narvaez J; Gómez-Vaquero C; Sabio JM; García-Portales R; González-Escribano MF; Tolosa C; Carreira P; Kiemeney L; Coenen MJH; Witte T; Schneider M; González-Gay MÁ; Martín J
    Sci Rep; 2018 May; 8(1):8195. PubMed ID: 29844438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of PTPN22 polymorphisms in SLE from western Mexico: correlation with mRNA expression and disease activity.
    Machado-Contreras JR; Muñoz-Valle JF; Cruz A; Salazar-Camarena DC; Marín-Rosales M; Palafox-Sánchez CA
    Clin Exp Med; 2016 Aug; 16(3):399-406. PubMed ID: 26013387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.
    Eilertsen GØ; Van Ghelue M; Strand H; Nossent JC
    Rheumatology (Oxford); 2011 Dec; 50(12):2197-205. PubMed ID: 21984763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Fajar DR; Rostinawati T; Hamijoyo L; Sahiratmadja E; Amalia R; Barliana MI
    Biologics; 2024; 18():95-106. PubMed ID: 38715569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.
    Palafox-Sánchez CA; Oregon-Romero E; Salazar-Camarena DC; Valle YM; Machado-Contreras JR; Cruz A; Orozco-López M; Orozco-Barocio G; Vázquez-Del Mercado M; Muñoz-Valle JF
    Clin Exp Med; 2015 Nov; 15(4):439-46. PubMed ID: 25253090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study.
    Panda AK; Tripathy R; Das BK
    Lupus; 2021 Feb; 30(2):219-227. PubMed ID: 33176568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients.
    Lin Z; Dan-Rong Y; Xiao-Qing T; Hao W; Hong-Lian G; Xian-Tao K; Ren-Qian Z; Jiyu L
    J Clin Lab Anal; 2007; 21(3):183-7. PubMed ID: 17506477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.
    Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Harris J; Hoi AY; Mackay F; Morand EF
    Lupus Sci Med; 2020 Jun; 7(1):. PubMed ID: 32546562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis.
    Kawasaki A; Tsuchiya N; Fukazawa T; Hashimoto H; Tokunaga K
    Genes Immun; 2002 Nov; 3(7):424-9. PubMed ID: 12424625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin-3A,
    Liu LN; Wang P; Zou YF; Xu Z; Cheng J; Zhang Y; Hu W; Pan HF
    Autoimmunity; 2019 Jun; 52(4):161-167. PubMed ID: 31394943
    [No Abstract]   [Full Text] [Related]  

  • 19. ICOS gene polymorphisms in systemic lupus erythematosus: A case-control study.
    Houssaini H; Bouallegui E; Abida O; Tahri S; Elloumi N; Hachicha H; Marzouk S; Bahloul Z; Masmoudi H; Fakhfakh R
    Int J Immunogenet; 2023 Aug; 50(4):194-205. PubMed ID: 37338463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.